rxstat › Shortages › Bupropion

Bupropion shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Bupropion products are in shortage in Canada (3 of 15 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 15, 2026.
Products affected
3 of 15
In shortage since
Feb 1, 2019
Est. full return
Jul 15, 2026
Reports on file
92
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
TEVA-BUPROPION XL
150MG · TABLET (EXTENDED-RELEASE) · TEVA CANADA LIMITED
DIN 02439654 · since Apr 22, 2026, est. end Jul 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-BUPROPION XL
300MG · TABLET (EXTENDED-RELEASE) · TEVA CANADA LIMITED
DIN 02439662 · since Apr 22, 2026, est. end Jul 15, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-BUPROPION XL
150MG · TABLET (EXTENDED-RELEASE) · TEVA CANADA LIMITED
DIN 02439654 · since Apr 22, 2026, est. end Jul 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
WELLBUTRIN SR
150MG · TABLET (EXTENDED-RELEASE) · VALEANT CANADA LP/VALEANT CANADA S.E.C.
DIN 02237825 · since Feb 1, 2019, no end estimate · Shortage of an active ingredient.
Resolved
TEVA-BUPROPION XL
300MG · TABLET (EXTENDED-RELEASE) · TEVA CANADA LIMITED
DIN 02439662 · ended Feb 18, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-BUPROPION XL
300MG · TABLET (EXTENDED-RELEASE) · SUN PHARMA CANADA INC
DIN 02475812 · ended May 15, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-BUPROPION XL
300MG · TABLET (EXTENDED-RELEASE) · SUN PHARMA CANADA INC
DIN 02475812 · ended Apr 25, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-BUPROPION XL
150MG · TABLET (EXTENDED-RELEASE) · SUN PHARMA CANADA INC
DIN 02475804 · ended May 1, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-BUPROPION XL
150MG · TABLET (EXTENDED-RELEASE) · SUN PHARMA CANADA INC
DIN 02475804 · ended Apr 10, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-BUPROPION XL
150MG · TABLET (EXTENDED-RELEASE) · TEVA CANADA LIMITED
DIN 02439654 · ended Mar 26, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-BUPROPION XL
300MG · TABLET (EXTENDED-RELEASE) · TEVA CANADA LIMITED
DIN 02439662 · ended Mar 3, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-BUPROPION XL
150MG · TABLET (EXTENDED-RELEASE) · TEVA CANADA LIMITED
DIN 02439654 · ended Feb 19, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Bupropion is currently affected by 3 active shortage reports filed with Health Canada by TEVA CANADA LIMITED, VALEANT CANADA LP/VALEANT CANADA S.E.C..

The reported causes are: disruption of the manufacture of the drug; shortage of an active ingredient. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Bupropion is classified under “ANTIDEPRESSANTS” (ATC N06AX).

Recent changes

Common questions

When will Bupropion be back in stock in Canada?

The latest manufacturer estimate is Jul 15, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Bupropion in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antidepressants)

Widespread shortageClomipramine3 of 4 reported products affected · est. return Jul 3, 2026Widespread shortageImipramine3 of 6 reported products affected · est. return Aug 28, 2026Partial shortageAmitriptyline15 of 34 reported products affected · est. return Jul 17, 2026Partial shortageCitalopram10 of 43 reported products affected · est. return Sep 30, 2026Partial shortageDesvenlafaxine2 of 17 reported products affected · est. return Jul 31, 2026Partial shortageDoxepin1 of 11 reported products affected

All antidepressants shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.